Kevin McLaughlin
Direttore/Membro del Consiglio presso VERICEL CORPORATION
Patrimonio netto: 567 630 $ in data 31/05/2024
Profilo
Fondatore di Aptius Education, Inc., Kevin F. McLaughlin è attualmente direttore finanziario, tesoriere e vicepresidente senior di Acceleron Pharma, Inc. È anche nel consiglio di Vericel Corp., Stealth BioTherapeutics Corp. e Stealth BioTherapeutics, Inc. Nella sua carriera passata ha occupato la posizione di direttore operativo e direttore di Aptius Education, Inc., direttore finanziario e vicepresidente senior di Qteros, Inc., direttore esecutivo e direttore di Praecis Pharmaceuticals, Inc., direttore finanziario e vicepresidente di Advanced TechCom, Inc., tesoriere e vicepresidente di Computervision Corp. e tesoriere e vicepresidente di Prime Computer, Inc. Kevin F. McLaughlin ha conseguito una laurea presso la Northeastern University e un MBA presso il Babson College.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
VERICEL CORPORATION
0.02% | 01/05/2024 | 11 900 ( 0.02% ) | 567 630 $ | 31/05/2024 |
Posizioni attive di Kevin McLaughlin
| Società | Posizione | Inizio |
|---|---|---|
| VERICEL CORPORATION | Direttore/Membro del Consiglio | 06/01/2015 |
| STEALTH BIOTHERAPEUTICS CORP | Direttore/Membro del Consiglio | 14/03/2017 |
| INVIVYD, INC. | Direttore/Membro del Consiglio | 21/05/2024 |
Stealth BioTherapeutics, Inc.
 Stealth BioTherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Stealth BioTherapeutics Corp., Stealth BioTherapeutics, Inc. develops therapies to treat mitochondrial dysfunctions and age-related diseases. The company is based in Newton, MA. The company was founded in 2007. Irene P. McCarthy has been the CEO of the company since 2009. | Direttore/Membro del Consiglio | 01/03/2017 |
Combined Therapeutics, Inc.
 Combined Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Combined Therapeutics, Inc. engages in biotechnology industry group. The company was founded by Romain Micol, Robert Langer, and Dan Anderson in and is headquartered in North Cambridge, MA. | Direttore/Membro del Consiglio | 08/03/2023 |
Precedenti posizioni note di Kevin McLaughlin
| Società | Posizione | Fine |
|---|---|---|
| DECIBEL THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 22/09/2023 |
| ACCELERON PHARMA INC. | Direttore Finanziario/CFO | 01/12/2021 |
Qteros, Inc.
 Qteros, Inc. Chemicals: SpecialtyProcess Industries Qteros, Inc. develops cellulosic ethanol transportation fuel. The firm utilizes a Q Microbe that converts all fermentable components of biomass to ethanol. The company was founded by Stephan Rogers, Jeffrey Hausthor, Susan Leschine, Jonathan Gorham, John Fabel and Jeffrey C. Sharp in 2006 and is headquartered in Amherst, MA. | Direttore Finanziario/CFO | - |
| Aptius Education, Inc. | Fondatore | 01/01/2009 |
| ░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░░░ | ░░░░░░░░░░ |
Formazione di Kevin McLaughlin
| Northeastern University | Undergraduate Degree |
| Babson College | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| VERICEL CORPORATION | Health Technology |
| DECIBEL THERAPEUTICS, INC. | Health Technology |
| INVIVYD, INC. | Health Technology |
| Aziende private | 10 |
|---|---|
Praecis Pharmaceuticals, Inc.
 Praecis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Praecis Pharmaceuticals, Inc. develops drugs and therapies for the treatment of cancer. The firm also develops peptide-based drugs. The company was founded 1993 and is headquartered in Waltham, MA. | Health Technology |
Advanced TechCom, Inc.
 Advanced TechCom, Inc. Telecommunications EquipmentElectronic Technology Part of World Access, Inc. (Georgia), Advanced TechCom, Inc. designs, manufactures and markets a line of digital microwave and millimeterwave radio systems. The company is based in Wilmington, MA. Advanced TechCom was acquired by World Access, Inc. (Georgia) on January 29, 1998 for $11.31 million. | Electronic Technology |
Computervision Corp.
 Computervision Corp. Packaged SoftwareTechnology Services Computervision Corporation is a private company that supplies electonic product definition solutions for company computer systems. The company is headquartered in Bedford, MA. | Technology Services |
Prime Computer, Inc.
 Prime Computer, Inc. Computer Processing HardwareElectronic Technology Prime Computer, Inc. manufactures mini computers and electronic components. It offers printers, projectors, consumer electronics, used monitors & desktop systems, software, protectors and video cards. The company was founded in 1972 and is headquartered in Marietta, GA. | Electronic Technology |
| Aptius Education, Inc. | |
Qteros, Inc.
Qteros, Inc. Chemicals: SpecialtyProcess Industries Qteros, Inc. develops cellulosic ethanol transportation fuel. The firm utilizes a Q Microbe that converts all fermentable components of biomass to ethanol. The company was founded by Stephan Rogers, Jeffrey Hausthor, Susan Leschine, Jonathan Gorham, John Fabel and Jeffrey C. Sharp in 2006 and is headquartered in Amherst, MA. | Process Industries |
Acceleron Pharma, Inc.
 Acceleron Pharma, Inc. BiotechnologyHealth Technology Acceleron Pharma, Inc. is a biopharmaceutical company, which engages in the discovery, development and commercialization of therapeutics to treat serious and rare diseases. Its product candidates include Luspatercept, designed to patients with chronic anemia associated within a wide range of blood diseases; ACE-083, designed for the treatment of focal muscle disorders; and Sotatercept, designed to treat pulmonary arterial hypertension. The company was founded by John L. Knopf and Thomas P. Maniatis on June 13, 2003 and is headquartered in Rahway, NJ. | Health Technology |
Stealth BioTherapeutics Corp.
 Stealth BioTherapeutics Corp. BiotechnologyHealth Technology Stealth BioTherapeutics Corp. is a clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of therapies for diseases involving mitochondrial dysfunction. The company was founded on April 3, 2006 and is headquartered in Needham, MA. | Health Technology |
Stealth BioTherapeutics, Inc.
Stealth BioTherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Stealth BioTherapeutics Corp., Stealth BioTherapeutics, Inc. develops therapies to treat mitochondrial dysfunctions and age-related diseases. The company is based in Newton, MA. The company was founded in 2007. Irene P. McCarthy has been the CEO of the company since 2009. | Health Technology |
Combined Therapeutics, Inc.
Combined Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Combined Therapeutics, Inc. engages in biotechnology industry group. The company was founded by Romain Micol, Robert Langer, and Dan Anderson in and is headquartered in North Cambridge, MA. | Commercial Services |
- Borsa valori
- Insiders
- Kevin McLaughlin
